论文信息 - A Quadruplet Regimen Comprising Carfilzomib, Cyclophosphamide, Lenalidomide, Dexamethasone (KCRD) Vs an Immunomodulatory Agent Containing Triplet (CTD/CRD) Induction Therapy Prior to Autologous Stem Cell Transplant: Results of the Myeloma XI Study - 字舞流文

A Quadruplet Regimen Comprising Carfilzomib, Cyclophosphamide, Lenalidomide, Dexamethasone (KCRD) Vs an Immunomodulatory Agent Containing Triplet (CTD/CRD) Induction Therapy Prior to Autologous Stem Cell Transplant: Results of the Myeloma XI Study

G. Morgan | W. Gregory | M. Drayson | N. Russell | M. Jenner | F. Davies | G. Cook | G. Jackson | D. Cairns | M. Kaiser | R. Owen | M. Garg | C. Pawlyn | J. Lindsay | K. Karunanithi | John R. Jones | A. Hockaday | B. Kishore | C. Williams | A. Striha | C. Collett